ArticleCancer immunology, immunotherapy : CII1994

Progression mechanisms in colon cancer: soluble interleukin-2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and tumour stage correlations.

A M Berghella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.